Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

EXPLAINED: Benzinga s top ratings upgrades downgrades for october 24 2022 - The Real Truth

Upgrades

Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter. The stock has a 52-week-high of $95.71 and a 52-week-low of $23.08. At the end of the last trading period, Teladoc Health closed at $24.03.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.